Seaport Therapeutics and Hemab Therapeutics are both charting a course for the public markets.
- Home |
- Seaport, Hemab prepare for IPO voyages to fund depression, clotting candidates
Seaport, Hemab prepare for IPO voyages to fund depression, clotting candidates
- April 12, 2026
Recent Posts
- Oil jumps 5% as Hormuz tanker attacks escalate, US Gulf hurricane shuts in production
- Crescent Energy to acquire Eagle Ford assets from Devon for $4.2 billion
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
